VistaGen Therapeutics (VTGN)
(Delayed Data from NSDQ)
$2.98 USD
-0.06 (-1.97%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.01 +0.03 (1.01%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
VistaGen Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
VTGN 2.98 -0.06(-1.97%)
Will VTGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VTGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VTGN
VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Misses Revenue Estimates
Exact Sciences (EXAS) Surpasses Q2 Earnings and Revenue Estimates
VTGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?
Opus Genetics, Inc. (IRD) Reports Q1 Loss, Tops Revenue Estimates
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates
Other News for VTGN
Is VTGN setting up for a drop? Fell Below 50 Day Moving Average shows up after slipping 1.97%
Crossed Above 50 Day Moving Average appears for VTGN after 4.83% move
50 Day Moving Average Resistance appears for VTGN after 0.34% move
Is VTGN gaining bearish strength? Fell Below 50 Day Moving Average shows up after plummeting 10.46%
Is VTGN positioned for a breakdown? Fell Below 20 Day Moving Average shows up after sliding 4.13%